kb NB 142-70

response biomarkers — cross-omics
Drug responseDRUG → MUTATIONCell line

Across CCLE and GDSC cell-line panels, response to kb NB 142-70 is significantly associated with the mutation status of multiple genes, with BREAST cell lines showing a particularly strong set of associations.

The most reproducible kb NB 142-70 response-associated genes across cancer lineages are SYNE2, ZNF208, and SPTBN2, each associated with drug response in up to 4 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The box plot shows the strongest observed association, kb NB 142-70 response grouped by SYNE2 status in BREAST.

Mutation status biomarkers of kb NB 142-70 response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BREASTSYNE2 →+2.852+0.375.023.00533
SKINZNF208 →-2.917-0.315.017.01133
LARGE_INTESTINESPTBN2 →+1.526+0.397.026.02933
LUNG_SCLCRP1 →-2.807-0.357.048.02432
LUNG_NSCLC_LUADPKD1 →+3.169+0.337.007.01132
BLOOD_LymphomaMYH6 →-2.951-0.237.025.03832
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

kb NB 142-70 response by SYNE2 status — BREAST

Box plot of kb NB 142-70 response in SYNE2-mutant vs wild-type cell lines in BREAST.

Explore this box plot interactively →

Exploration